Hubei Biocause Pharmaceutical Co., Ltd. (SHE: 000627)

Market Cap	21.59B
Revenue (ttm)	40.70B
Net Income (ttm)	-771.87M
Shares Out	4.94B
EPS (ttm)	-0.15
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	176,383,170
Open	4.950
Previous Close	5.040
Day's Range	4.660 - 5.020
52-Week Range	1.610 - 5.420
Beta	0.71
Analysts	n/a
Price Target	n/a
Earnings Date	Apr 29, 2025

About Hubei Biocause Pharmaceutical

Hubei Biocause Pharmaceutical Co., Ltd. primarily provides life and motor insurance products in China. It also engages in the pharmaceutical, chemical, and new energy fuel businesses. In addition, the company is involved in the contract research and production of APIs, intermediates, and formulations, including tablets, granules, capsules, etc.; and provision of chemicals comprising dimethyl ether gas and a-chloropropionyl chloride. It exports its products to approximately 85 countries, including the United States, the European Union, and inter...

• Industry: Insurance - Life
• Sector: Financials
• CEO: Wenxia Zhou
• Employees: 1,765
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000627